Internet Explorer does not cooperate well with this platform. Please see below for options that work with APNA eLearning Center programs.* 

3055-23:  Buprenorphine Induction in the Era of Fentanyl: Avoiding Precipitated Withdrawal Symptoms

This presentation introduces concepts related to buprenorphine microdosing for patients using fentanyl. As fentanyl is highly potent and lipophilic, patients using fentanyl are at higher risk for precipitated withdrawal. The participant will leave with the knowledge and skills required to implement high-quality, evidence-based care for those with opioid use disorder.

Presenters:  Brayden Kameg, DNP, PMHNP-BC, CARN, CNE; Gabrielle Najarian Hart, BSN, RN; Rebecca Burkart, BSN, RN

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss best practices related to buprenorphine induction in those using fentanyl.

Keywords:  Buprenorphine, Opioid Use, Substance Use

Nursing Continuing Professional Development:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Price: Free through September 29, 2024 

Grant Statement:

Funding for this initiative was made possible (in part) by grant no. 1H79TI0855888-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Access to this course will end:  November 30, 2025

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.